Cargando…
Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201506/ https://www.ncbi.nlm.nih.gov/pubmed/37217487 http://dx.doi.org/10.1038/s41392-023-01482-9 |
| _version_ | 1785045277952966656 |
|---|---|
| author | Jiang, Zhidong Feng, Bo Zhang, Yumin Nie, Tianqing Liu, Hong Li, Jia Su, Haixia Zhang, Leike Zang, Yi Zhou, Yu |
| author_facet | Jiang, Zhidong Feng, Bo Zhang, Yumin Nie, Tianqing Liu, Hong Li, Jia Su, Haixia Zhang, Leike Zang, Yi Zhou, Yu |
| author_sort | Jiang, Zhidong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10201506 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102015062023-05-23 Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment Jiang, Zhidong Feng, Bo Zhang, Yumin Nie, Tianqing Liu, Hong Li, Jia Su, Haixia Zhang, Leike Zang, Yi Zhou, Yu Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-05-22 /pmc/articles/PMC10201506/ /pubmed/37217487 http://dx.doi.org/10.1038/s41392-023-01482-9 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Jiang, Zhidong Feng, Bo Zhang, Yumin Nie, Tianqing Liu, Hong Li, Jia Su, Haixia Zhang, Leike Zang, Yi Zhou, Yu Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment |
| title | Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment |
| title_full | Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment |
| title_fullStr | Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment |
| title_full_unstemmed | Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment |
| title_short | Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment |
| title_sort | discovery of novel non-peptidic and non-covalent small-molecule 3cl(pro) inhibitors as potential candidate for covid-19 treatment |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201506/ https://www.ncbi.nlm.nih.gov/pubmed/37217487 http://dx.doi.org/10.1038/s41392-023-01482-9 |
| work_keys_str_mv | AT jiangzhidong discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT fengbo discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT zhangyumin discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT nietianqing discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT liuhong discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT lijia discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT suhaixia discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT zhangleike discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT zangyi discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment AT zhouyu discoveryofnovelnonpeptidicandnoncovalentsmallmolecule3clproinhibitorsaspotentialcandidateforcovid19treatment |